Chanan-Khan Asher 4
4 · Cellectar Biosciences, Inc. · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Chanan-Khan Asher
Director
Transactions
- Award
Stock option (right to buy)
2025-02-14+60,000→ 60,000 totalExercise: $0.29Exp: 2035-02-14→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date.